fluorobenzenes has been researched along with Hypertriglyceridemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calza, L; Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J | 1 |
| Carlson, DM; Gold, A; Jones, PH; Kelly, MT; McKenney, JM; Roth, EM; Setze, CM; Stolzenbach, JC; Williams, LA | 1 |
| Ballantyne, CM; Jones, PH; Kelly, MT; Lele, A; Setze, CM; Stolzenbach, JC; Thakker, KM | 1 |
| Abaigar-Luquin, P; Izquierdo-Ortiz, MJ | 1 |
| Bernal-Rosales, LP; Cervantes, JL; Gonzalez, JG; Marin, JA; Martinez, G; Ocampo, R; Polanco, A; Rodriguez-Briones, I; Sanchez-Mijangos, H; Talavera, JO | 1 |
| McTaggart, F; Olsson, AG; Raza, A | 1 |
| Bays, HE; Chitra, RR; Hunninghake, DB; Rader, DJ; Schneck, DW; Simonson, SG; Stein, EA | 1 |
| Ebihara, Y; Fox, JC; Saito, Y; Sasaki, J; Shirai, K; Yamada, N; Yanase, T | 1 |
| Gandhi, SK; Ghali, JK; Hassman, DR; Insull, W; Miller, E; Y As, JW | 1 |
1 review(s) available for fluorobenzenes and Hypertriglyceridemia
| Article | Year |
|---|---|
Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.
Topics: Animals; Cholesterol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2002 |
6 trial(s) available for fluorobenzenes and Hypertriglyceridemia
| Article | Year |
|---|---|
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Fenofibrate; Fluorobenzenes; Humans; Hypercholesterolemia; Hypertriglyceridemia; Liver; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2010 |
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
Topics: Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Fenofibrate; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides | 2011 |
A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Metabolic Syndrome; Mexico; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2013 |
Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.
Topics: Analysis of Variance; Apolipoproteins; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Lipoproteins; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2004 |
Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
Topics: Apolipoproteins; Bezafibrate; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Japan; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2007 |
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Coronary Disease; Creatinine; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Managed Care Programs; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2007 |
3 other study(ies) available for fluorobenzenes and Hypertriglyceridemia
| Article | Year |
|---|---|
Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids.
Topics: Adult; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2009 |
Severe hypertriglyceridaemia. Treatment with plasmapheresis.
Topics: Acrylic Resins; Combined Modality Therapy; Fenofibrate; Filtration; Fluorobenzenes; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Molecular Weight; Plasmapheresis; Practice Guidelines as Topic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
Rosuvastatin--a new lipid-lowering drug.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Pleurodynia, Epidemic; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2003 |